Abstract:Purpose Mitofusin 2 (Mfn2) is one of two mitofusins involved in regulating mitochondrial size, shape and function, including mitophagy, an important cellular mechanism to limit oxidative stress. Reduced expression of Mfn2 has been associated with impaired osteoblast differentiation and function and a reduction in the number of viable osteocytes in bone. We hypothesized that the genetic absence of Mfn2 in these cells would increase their susceptibility to aging-associated metabolic stress, leading to a progressive impairment in skeletal homeostasis over time. Methods Mfn2 was selectively deleted in vivo at three different stages of osteoblast lineage commitment by crossing mice in which the Mfn2 gene was floxed with transgenic mice expressing Cre under the control of the promoter for Osterix (OSX), collagen1a1, or DMP1 (Dentin Matrix Acidic Phosphoprotein 1). Results Mice in which Mfn2 was deleted using DMP1-cre demonstrated a progressive and dramatic decline in bone mineral density (BMD) beginning at 10 weeks of age ( n = 5 for each sex and each genotype from age 10 to 20 weeks). By 15 weeks, there was evidence for a functional decline in muscle performance as assessed using a rotarod apparatus ( n = 3; 2 males/ 1 female for each genotype), accompanied by a decline in lean body mass. A marked reduction in trabecular bone mass was evident on bone histomorphometry, and biomechanical testing at 25 weeks (k/o: 2 male/1 female, control 2 male/2 female) revealed severely impaired femur strength. Extensive regional myofiber atrophy and degeneration was observed on skeletal muscle histology. Electron microscopy showed progressive disruption of cellular architecture, with disorganized sarcomeres and a bloated mitochondrial reticulum. There was also evidence of neurodegeneration within the ventral horn and roots of the lumbar spinal cord, which was accompanied by myelin loss and myofiber atrophy. Deletion of Mfn2 using OSX-cre or Col1a1-cre did not result in a musculoskeletal phenotype. Where possible, male and female animals were analyzed separately, but small numbers of animals in each group limited statistical power. For other outcomes, where sex was not considered, small sample sizes might still limit the strength of the observation. Conclusion Despite known functional overlap of Mfn1 and Mfn2 in some tissues, and their co-expression in bone, muscle and spinal cord, deletion of Mfn2 using the 8 kB DMP1 promoter uncovered an important non-redundant role for Mfn2 in maintaining the neuromuscular/bone axis.

Osteomyelosclerosis, anemia and extramedullary hematopoiesis in mice lacking the transcription factor NFATc2

C/Ebp Alpha Regulates Osteoclast Lineage Commitment

Nuclear factor of activated T cells 2 is required for osteoclast differentiation and function in vitro but not in vivo

Aberrant Alternative Splicing in U2af1/Tet2 Double Mutant Mice Contributes to Major Hematological Phenotypes

Autoamplification of NFATc1 expression determines its essential role in bone homeostasis

Role of nuclear factor of activated T cells in chondrogenesis osteogenesis and osteochondroma formation

Expression and regulation of NFAT (nuclear factors of activated T cells) in human CD34+ cells: down-regulation upon myeloid differentiation

The collection of NFATc1-dependent transcripts in the osteoclast includes numerous genes non-essential to physiologic bone resorption

Mice Lacking C-Fos Have Normal Hematopoietic Stem Cells but Exhibit Altered B-cell Differentiation Due to an Impaired Bone Marrow Environment

Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos

Fosl2 Deficiency Predisposes Mice to Osteopetrosis, Leading to Bone Marrow Failure

Bone marrow sinusoidal endothelium controls terminal erythroid differentiation and reticulocyte maturation

C/Ebp Alpha Controls Osteoclast Terminal Differentiation, Activation, Function, And Postnatal Bone Homeostasis Through Direct Regulation Of Nfatc1

Nuclear Factor Erythroid 2 Regulates Human HSC Self-Renewal and T Cell Differentiation by Preventing NOTCH1 Activation

The EMT Transcription Factor Zeb2 Controls Adult Murine Hematopoietic Differentiation by Regulating Cytokine Signaling.

Decreased osteogenesis in mesenchymal stem cells derived from the aged mouse is associated with enhanced NF-κB activity

Mitofusin 2 plays a critical role in maintaining the functional integrity of the neuromuscular-skeletal axis

Activation of NFAT signal in vivo leads to osteopenia associated with increased osteoclastogenesis and bone-resorbing activity

Defective osteogenesis of the stromal stem cells predisposes CD18-null mice to osteoporosis.

Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice

Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation